Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 770125 10.3389/fphar.2021.770125 Pharmacology Correction Corrigendum: Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review Yang et al. Corrigendum: CPMs for COVID-19 Yang Zhi-Hua 1 2 † Wang Bin 2 † Ma Qian 1 2 Wang Lin 1 2 Lin Ya-Xin 2 Yan Hai-Feng 1 2 Fan Zi-Xuan 1 2 Chen Hao-Jia 1 2 Ge Zhao 1 2 Zhu Feng 3 Wang Hui-Jie 4 Zhang Bao-Nan 4 Sun Hai-Dong 5 6 * Feng Li-Min 7 * First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China Tianjin University of Traditional Chinese Medicine, Tianjin, China Department of Traditional Chinese Medicine, Hebei North University, Zhangjiakou, China Department of Cardiology, Traditional Chinese Medicine Hospital of Tianjin Beichen District, Tianjin, China Tianjin Fourth Central Hospital, Tianjin, China Shenzhen Hospital Futian of Guangzhou University of Chinese Medicine, Shenzhen, China Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Li-Min Feng, flimintcm@163.com; Hai-Dong Sun, shd02@163.com

These authors have contributed equally to this work and share first authorship

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 25 10 2021 2021 12 770125 03 09 2021 29 09 2021 Copyright © 2021 Yang, Wang, Ma, Wang, Lin, Yan, Fan, Chen, Ge, Zhu, Wang, Zhang, Sun and Feng. 2021 Yang, Wang, Ma, Wang, Lin, Yan, Fan, Chen, Ge, Zhu, Wang, Zhang, Sun and Feng

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Potential Mechanisms of Action of Chinese Patent Medicines for COVID-19: A Review by Yang, Z-H., Wang, B., Ma, Q., Wang, L., Lin, Y-X., Yan, H-F., Fan, Z-X., Chen, H-J., Ge, Z., Zhu, F., Wang, H-J., Zhang, B-N., Sun, H-D., and Feng, L-M. (2021). Front. Pharmacol. 12:668407. doi: 10.3389/fphar.2021.668407 COVID-19 SARS-CoV-2 traditional Chinese medicines Chinese patent medicines review

Incorrect Affiliation

In the published article, there was an error in affiliation “6”. Instead of “Shenzhen Hospital Futian of Guangzhou University of Chinese Medicine, Tianjin, China”, it should be “Shenzhen Hospital Futian of Guangzhou University of Chinese Medicine, Shenzhen, China”.

We apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.